Cataract surgery has undergone many developments since J. Stuart Cumming, MD, FACS, FRCOphth, began his career, yet he continues to be a leading voice in IOL development.
Cumming, the developer of the Crystalens (now owned by Bausch + Lomb) and founder of Cumming Ophthalmic Research and Development (CORD), remembered that the ciliary muscle still functioned in older patients. This led to his decades-long mission to create an accommodating IOL.
Healio/OSN spoke with Cumming about his years of experience, including his journey from an OB/GYN specialist to one of ophthalmology’s leading